Vitrolife AB logo

VITR - Vitrolife AB News Story

SEK244 1.8  0.7%

Last Trade - 9:36am

Sector
Healthcare
Size
Mid Cap
Market Cap £2.32bn
Enterprise Value £2.26bn
Revenue £117.4m
Position in Universe 183rd / 1787

BRIEF-Vitrolife Q1 EBITDA Falls To SEK 116 Million

Thu 23rd April, 2020 7:11am
April 23 (Reuters) - Vitrolife AB  VITR.ST :
    * MARCH 2020: GOOD GROWTH BUT UNCERTAIN SECOND QUARTER
    * Q1 SALES AMOUNTED TO SEK 334 (312) MILLION, CORRESPONDING
TO AN
INCREASE OF 7 PERCENT IN SEK
    * Q1 EBITDA SEK 116 MILLION VERSUS SEK 126 MILLION YEAR AGO
    * DUE TO GREAT UNCERTAINTY PREVAILING FROM EXTENSIVE SPREAD
OF
COVID-19, VITROLIFE'S BOARD DECIDED TO POSTPONE ANNUAL GENERAL
MEETING TO A LATER DATE
    * LARGE REDUCTION IN INFLOW OF ORDERS DUE TO COVID-19 DURING
BEGINNING OF Q2
    * SALES DURING FIRST WEEKS OF APRIL AMOUNTED TO
APPROXIMATELY A
THIRD OF THOSE IN CORRESPONDING PERIOD PREVIOUS YEAR

Source text for Eikon:  ID:nWkr1pQyK4 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.